{
    "items": [
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/how-best-to-test-ebola-treatments?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.tropicalmedicine.ox.ac.uk/news/how-best-to-test-ebola-treatments/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Ebola virus\" srcset=\"https://www.tropicalmedicine.ox.ac.uk/news/how-best-to-test-ebola-treatments/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.tropicalmedicine.ox.ac.uk/news/how-best-to-test-ebola-treatments/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.tropicalmedicine.ox.ac.uk/news/how-best-to-test-ebola-treatments/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/how-best-to-test-ebola-treatments\" title=\"An unconventional clinical trial design might have advantages over classical trials for testing treatments for Ebola virus disease (EVD), suggests a study published this week in PLOS Medicine. The work of an international team led by John Whitehead of Lancaster University, UK and Ben Cooper (Oxford University, UK, and Mahidol Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand) provides much-needed data to inform a debate on the scientific and ethical justification for non-randomized EVD trials that has taken place in the editorial pages of a number of medical journals in past months.\" itemprop=\"name\" class=\"state-published\">How best to test Ebola treatments</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">14 April 2015</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/search?category=moru\" title=\"MORU\">\n\t\t                <span class=\"label label-primary\">MORU</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">An unconventional clinical trial design might have advantages over classical trials for testing treatments for Ebola virus disease (EVD), suggests a study published this week in PLOS Medicine. The work of an international team led by John Whitehead of Lancaster University, UK and Ben Cooper (Oxford University, UK, and Mahidol Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand) provides much-needed data to inform a debate on the scientific and ethical justification for non-randomized EVD trials that has taken place in the editorial pages of a number of medical journals in past months.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/artemisinin-resistant-malaria-established-across-myanmar-now-within-25km-of-indian-border?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.tropicalmedicine.ox.ac.uk/news/artemisinin-resistant-malaria-established-across-myanmar-now-within-25km-of-indian-border/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"Maps of Myanmar showing the progression of malaria resistance\" srcset=\"https://www.tropicalmedicine.ox.ac.uk/news/artemisinin-resistant-malaria-established-across-myanmar-now-within-25km-of-indian-border/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.tropicalmedicine.ox.ac.uk/news/artemisinin-resistant-malaria-established-across-myanmar-now-within-25km-of-indian-border/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.tropicalmedicine.ox.ac.uk/news/artemisinin-resistant-malaria-established-across-myanmar-now-within-25km-of-indian-border/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/artemisinin-resistant-malaria-established-across-myanmar-now-within-25km-of-indian-border\" title=\"Bangkok / Oxford (UK), 20 February 2015 - Resistance to the antimalarial drug artemisinin is established in Myanmar and has reached within 25km of the Indian border, a study published today in Lancet Infectious Diseases reports. Artemisinin resistance threatens to follow the same historical trajectory from Southeast Asia to the Indian subcontinent as seen in the past with other antimalarial medicines.\" itemprop=\"name\" class=\"state-published\">Artemisinin-resistant malaria established across Myanmar, now within 25km of Indian border</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">20 February 2015</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/search?category=moru\" title=\"MORU\">\n\t\t                <span class=\"label label-primary\">MORU</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Bangkok / Oxford (UK), 20 February 2015 - Resistance to the antimalarial drug artemisinin is established in Myanmar and has reached within 25km of the Indian border, a study published today in Lancet Infectious Diseases reports. Artemisinin resistance threatens to follow the same historical trajectory from Southeast Asia to the Indian subcontinent as seen in the past with other antimalarial medicines.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/genetics-underpinning-antimalarial-drug-resistance-revealed?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n        \n        <img src=\"https://www.tropicalmedicine.ox.ac.uk/news/genetics-underpinning-antimalarial-drug-resistance-revealed/responsive_image?ratio=r16x9&amp;scale=w760\" alt=\"5 maps of South East Asia showing various genetic markers of malaria resistance\" srcset=\"https://www.tropicalmedicine.ox.ac.uk/news/genetics-underpinning-antimalarial-drug-resistance-revealed/responsive_image?ratio=r16x9&amp;scale=w1140 1140w, https://www.tropicalmedicine.ox.ac.uk/news/genetics-underpinning-antimalarial-drug-resistance-revealed/responsive_image?ratio=r16x9&amp;scale=w760 760w, https://www.tropicalmedicine.ox.ac.uk/news/genetics-underpinning-antimalarial-drug-resistance-revealed/responsive_image?ratio=r16x9&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/genetics-underpinning-antimalarial-drug-resistance-revealed\" title=\"Largest genome-wide study of parasite provides clearest picture yet of genetic changes driving artemisinin resistance\r\nartemisinin-genetics-resistance. Hinxton, Cambridge, UK, 19 January 2015 \u2013 The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin.\" itemprop=\"name\" class=\"state-published\">Genetics underpinning antimalarial drug resistance revealed</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">19 January 2015</span>\n                    \n                </p>\n\n                \n                    \n\n    \n    \n        <ul class=\"list-unstyled list-inline categories-list\">\n\t        \n\t        \t\t<li>\n\t\t            <a href=\"https://www.tropicalmedicine.ox.ac.uk/news/search?category=moru\" title=\"MORU\">\n\t\t                <span class=\"label label-primary\">MORU</span>\n\t\t            </a>\n\t\t        </li>\n\t        \n\t   \t</ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Largest genome-wide study of parasite provides clearest picture yet of genetic changes driving artemisinin resistance\r\nartemisinin-genetics-resistance. Hinxton, Cambridge, UK, 19 January 2015 \u2013 The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n"
    ], 
    "more": "\n\n    \n\n", 
    "msg": ""
}